The role of Tc99m-sestamibi scintimammography in combination with the triple assessment of primary breast cancer

European Journal of Surgical Oncology

Volumn 28, Issue 2, 2002, Pages 108-112

  Leidenius, M H K ^a   Leppanen E A ^a   Tykka H T ^a   Von Smitten, K A J ^a  

^a Maria Hospital   (Finland)

Author keywords

Breast cancer; Diagnosis; Scintimammography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; ASPIRATION CYTOLOGY; BREAST CANCER; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; ECHOMAMMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; NEEDLE BIOPSY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY;

EID: 0036491216     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2001.1217     Document Type: Article

References (28)

1. Scintimammography: The complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma
2. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement
3. Scintimammography in the diagnosis of breast cancer
4. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions
5. m-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: A comparison with mammography and histopathological diagnosis
6. 99mTc-sestamibi
7. Technetium-99m sestamibi scintimammography: The influence of histopathological characteristics, lesion size and the presence of carcinoma in situ in the detection of scintimammography
8. m-MIBI scintimammography in 300 consecutive patients: Factors that may affect accuracy
9. 99mTc-MIBI scintimammography as a complement of the mammography in patients with suspected breast cancer. A multicentre experience
10. Scintimammography with technetium-99m metoxyisobutylisonitrile: Results of a prospective European multicentre trial
11. 99mTc-sestamibi as a complementary diagnostic technique in the detection of breast cancer
12. Quality control in the locoregional treatment of breast cancer
13. Analysis of false results in a series of 835 fine needle aspirates of breast lesions
14. Value of fine needle aspiration in the diagnosis of breast lesions
15. Ultrasound-guided fine-needle aspiration (FNA) of nonpalpable breast lesions. A review of 1885 FNA cases using the National Cancer Institute-supported recommendations on the uniform approach to breast FNA
16. Quality assurance in the diagnosis of breast disease
17. 99mTc-sestamibi scintimammography and sonography in the diagnostic workup of breast masses
18. Reducing the cost of diagnosis of breast carcinoma. Impact of ultrasound and imaging-guided biopsies on a clinical breast practice
19. Breast cancer detection with 99m-Tc-sestamibi scintigraphy mammography, and fine needle aspiration cytology: Comparative study in 64 surgically treated patients
20. Scintimammography enhances negative predictive value of non-invasive preoperative assessment of breast lesions
21. Prediction of usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves
22. Role of tecnetium-99m sestamibi scintimammography and contrast enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms
23. Detection of DCIS using Tc-99m MIBI scintimammography
24. Ductal carcinoma in situ (DCIS) of the breast: Diagnostic and therapeutic controversies
25. Invasive lobular carcinoma: Mammographic findings in a 10-year experience
26. Specimen adequacy and false-negative diagnosis rate in fine-needle aspirates of palpable breast masses
27. Comparison of technetium - 99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions
28. Fine needle aspiration of the breast: Diagnosis and pitfalls: A review of 3545 cases